Quarterly report pursuant to Section 13 or 15(d)

Document And Entity Information

v3.10.0.1
Document And Entity Information - shares
3 Months Ended
Jun. 30, 2018
Aug. 14, 2018
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2018  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q1  
Entity Registrant Name Bionik Laboratories Corp.  
Entity Central Index Key 0001508381  
Current Fiscal Year End Date --03-31  
Entity Filer Category Smaller Reporting Company  
Trading Symbol BNKL  
Entity Common Stock, Shares Outstanding   350,383,160